Skip to main content

Table 2 Medication use in cases of incident sarcoidosis

From: Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study

  N (%) Mean time from diagnosis to first treatment (days)
Systemic steroid 2340 (78.0) 49.0 (85.9)
 prednisolone 1666 (55.6) 44.7 (81.9)
 methylprednisolone 885 (29.5) 106.9 (113.8)
 dexamethasone 659 (22.0) 153.5 (110.2)
 use for > 30 days 1527 (50.9) 19.4 (45.6)
Topical steroid 627 (20.9) 155.5 (114.7)
 hydrocortisone 180 (6.0) 172.2 (110.6)
 betamethasone 159 (5.3) 172.0 (112.6)
 methylprednisolone 148 (4.9) 125.9 (120.3)
Other immunosuppressant 263 (8.8) 96.5 (109.7)
 methotrexate 131 (4.4) 91.7 (104.2)
 cyclosporin 85 (2.8) 130.2 (117.3)
 azathioprine 72 (2.4) 99.1 (112.0)
 use for > 30 days 180 (6.0) 69.5 (85.9)
Hydroxychloroquine 123 (4.1) 50.3 (86.6)
 use for > 30 days 97 (3.2) 47.3 (80.6)
None 575 (19.2)  
  1. Data are presented as number (%) or mean (standard deviation), unless otherwise indicated